Global transgenic animals market research report: by products (gene gun, microinjection), techniques (DNA microinjection), consumables (probes), application (monoclonal Abs), transgenic animals (mice) end user (biotech industries) – Forecast till 2027
The global transgenic animals market is eyeing for a stellar 8.60% CAGR during the forecast period (2017-2023), reports Market Research Future (MRFR). This covers the drivers and various segmentation with a detailed analysis of the same for a precise market overview and a rationally laid-out prediction. The market is founded on the technology of insertion of a foreign gene into an animal’s genome where, by recombining it then with the animal’s DNA, researchers can obtain the much-desired result. The procedure can impact global healthcare significantly, especially at a time, when cases of chronic diseases such as cancer, diabetes and other cardiovascular diseases are recording an upturn. Rising healthcare expenditure is substantially complimenting it by creating a niche for such researches. Expanding biotechnology sector is also a driver for transgenic animals’ market. Its astounding market value of USD 139.4 billion can speak for the inflating industry, and surely transgenic animals’ market can profit from it.
On the flip side, stringent FDA policies can act like a hurdle for the market in the forthcoming future and reluctance to accept the resultant products, coupled with high developmental cost, can bottleneck the expected flow. But the rising willingness to adopt a healthy lifestyle can steer the sector away from such deterrents.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5464
The global transgenic animals market can be segmented by product, techniques, consumables, application, model organisms, and end-user.
Based on product, the market can be segmented into peak cell rate (PCR), gene gun, microinjections, electroporator, and others. PCR can be sub-segmented into real-time PCR, digital PCR systems, and others. Techniques-wise, the market comprises retrovirus-mediated gene transfer, embryonic stem cell-mediated gene transfer, DNA microinjection, and others. Consumable-based segmentation includes fluorescent probes, culture media, and others. Application-wise segmentation consists recombinant human proteins, monoclonal antibodies, xenotransplantation, and others. Based on model organisms, the market can be segmented into mice, rabbit, cows, and others. Based on the end-user, the market is segmented into biotechnology industries, research organizations, academic institutes, and others.
Region-specific segmentation of the transgenic animals market includes the Americas, Europe, Asia Pacific (APAC), and the Middle East Africa (MEA).
Advanced technology, better infrastructure, higher healthcare expenditure and a huge patient pool suffering from chronic diseases are giving the American market much-needed thrust owing to which the region has grabbed the top spot. Europe has occupied the second position, and its driving factors are quite similar to that of the Americas market. Furthermore, the U.K. is boosting the region’s prospect as the fourth-largest contributor worldwide. The APAC is expected to be the fastest growing region in the global market. With developing economies such as China and India showing great interest in the sector, the region is expected to rise further. On the other hand, the MEA is going to have the least share owing to the presence of several poor economies and dearth in research expenditures.
The competitive market is relying heavily on strategies involving collaborations, mergers, and acquisitions for further expansion. For instance, Cyagen Biosciences collaboration with Taconic Biosciences can impact the market considerably. Charles River’s acquisition of MPI Researches can also be considered exemplary in this case.
Key market players to influence the global transgenic animals market are Cyagen Biosciences, Charles River, Creative-Biolabs, TRANS GENIC INC.., Ltd., Sutter Instrument Company, Bio-Rad Laboratories, Inc., Spinco Biotech Pvt Ltd., Abbott, Thermo Fisher Scientific Inc., Sigma-Aldrich Co., Accumold, and others.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/transgenic-animals-market-5464
A recent article published in Science Translational Medicine reveals that genetically humanized mice are responding better to Hepatitis Delta Virus (HDV) than before. Upon insertion of Hepatitis B virus (HBV) in the body of the mice, HDV establishes itself as a persistent infection which then the mice counter with defensive mechanisms. Healthcare sector can gain from such research.
On the other hand, a recent report published by the University of California regarding suggests the possibility of new cancer treatment. Findings came with a review of natural killer cells, grown from human induced pluripotent stem (IPS) cells, which are now proving advantageous against ovarian cancer in a mouse model.
You may also be interested in..
Anti-Neoplastic Agents Market Research Report – Forecast 2027
Global Anti Asthma Drugs Market – Forecast to 2027
Uterine Fibroid Market Research Report - U.S. Forecast to 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future
+1 646 845 9312
Email: [email protected]